Login or Create Account

Resources with keywords: interferon

Training Tools & Resources
SARS-CoV-2/COVID-19


Early Treatment with Pegylated Interferon Lambda for Covid-19 (Website)
The New England Journal of Medicine (NEJM)
9 February 2023

Reis G, et.al.
Among predominantly vaccinated outpatients with Covid-19, the incidence of hospitalization or an emergency department visit was significantly lower among those who received a single dose of pegylated interferon lambda than among those who received placebo.

keywords: covid-19, interferon, treatment, vaccines

Not a member and would like updates and notifications?

Quick Links: HOME | ABOUT | MEMBERSHIP | EDUCATION | CALENDAR | RESOURCES | CREDENTIALS

Also from ABSA International: Applied Biosafety: Journal of ABSA International | ABSA Job Board | BiosafetyBuyersGuide.org | Annual Biosafety and Biosecurity Conference | International Biosecurity Symposium | USDA ARS International Biosafety & Biocontainment Symposium | Biosafety & Biosecurity Training Course (BBTC®) | Principles & Practices of Biosafety® | my.ABSA.org | Risk Group Database | LAI Database | connect.ABSA.org

ABSA International
1200 Allanson Road, Mundelein, IL 60060-3808
1-866-425-1385 (toll free) or 847-949-1517
info@absa.org | Contact ABSA

Copyright © ABSA International. All Rights Reserved. Privacy Policy

ABSA International does not endorse, promote, review, or warrant the accuracy of the products and services offered by those parties who link to the ABSA International website. The links are merely provided as a convenience to the visitors of this site, and ABSA International may or may not be compensated for permitting the link to be displayed on this page.

Go to Top